TheraBiogen Inc. fka TRAB

[farkas]

10Q filing states: "We generated sales during the three months ended May 31, 2012 of $(1,241). Gross sales were approximately $756 reduced by rebates, discounts and marketing allowances of approximately $1,996 which then resulted in negative revenue due to the application of those rebates, discounts and marketing allowances."

It is hard to find companies that can show negative sales revenues. Well done TRAB. These figures hopefully represent the bottom range.

Lets hope that these numbers are history and that we will have a better future in the coming quarters.

My target price of 1 cent may be coming soon.

Farkas